Cancer News: Other
New drug Afinitor® (everolimus) reduced the disease progression risk in patients with advanced, nonfunctional neuroendocrine tumors of gastrointestinal or lung origin.
A new study reveals that for metastatic cancer patients, an individualized approach would be beneficial to select the most appropriate and effective therapy.
Patients with gastrointestinal stromal tumors may develop additional malignancies before and after their diagnosis, according to the first population-based study.
Ruxolitinib was approved in EU for the treatment of adult patients of a rare and incurable blood cancer associated with an overproduction of blood cells.
The addition of chemotherapy to post-surgical radiation treatment is not effective in treating vulvar cancer according to the latest research.
Adrenocortical carcinoma, a rare and dangerous endocrine malignancy with no effective drug treatments, may respond to targeted therapies, early studies suggest.
An accurate cancer diagnosis is particularly important for rare cancers, which present additional challenges, and inaccurate diagnoses present major obstacles.
Scientists are building proteins that act on the tumor cell surface, and increase immune function against some tumors. Their work is still in laboratory phase.
New research showed that a less invasive technique for vulvar cancer reduced complications while maintaining a low rate of future occurrence.